Voices
Amol Akhade: Last day at WCLC 2026, King Keytruda survived?
Amol Akhade/LinkedIn

Amol Akhade: Last day at WCLC 2026, King Keytruda survived?

Amol Akhade, Senior Consultant at Fortis Hospitals Mumbai, shared on LinkedIn:

“Last day at WCLC 2026

King Keytruda survived?

I Think so. What you think? Harmoni-2 trial.”

Amol Akhade

You might be interested in:

HARMONi-6 Trial at ASCO Plenary 2026: Ivonescimab Plus Chemotherapy Improves Overall Survival in Advanced Squamous Non-Small Cell Lung Cancer

Amol Akhade: Last day at WCLC 2026, King Keytruda survived?

 

Amol Akhade cancer HARMONi-2 Harmoni-2 trial King Keytruda Lung cancer NSCLC OncoDaily Oncology WCLC-2026 WCLC26